Topic: Brain and Nerve Health
AP News | 2010-03-03 16:32:27
Medivation loses about two-thirds of value on negative study results for Alzheimer's drug
Shares of Medivation Inc. plunged Wednesday after the failure of Dimebon, an Alzheimer's drug the company is developing with Pfizer Inc. Medivation stock lost about two-thirds of its value and fell to an annual low Wednesday morning. Before the market opened, Medivation and Pfizer said ...
AP News | 2010-03-01 19:16:40
During a helicopter medevac mission by the U.S. Army's 82nd Airborne, or Task Force Pegasus, an Afghan man with a life-threatening head injury receives medical treatment while en route to a field hospital, airborne over Helmand province, Afghanistan ...
Reuters US Online Report Health News | 2010-03-01 01:59:53
LONDON (Reuters) - New imaging technology suggests an experimental drug for Alzheimer's reduces clumps of plaque in the brain by around 25 percent, lifting hopes for a medicine that disappointed in clinical tests two years ago. Bapineuzumab -- being developed by Pfizer Inc, Irish drugmaker Elan Corp and Johnson & Johnson -- is a potential game-changer because it could be the first ...
WENN | 2010-03-01 00:26:00
Wolfgang Puck and Thomas Keller
Keep Memory Alive's Power of Love Gala to Benefit The Cleveland Clinic Lou Ruvo Center for Brain Health at The Bellagio Resort Casino
Las Vegas, Nevada - 27.02.10
Copyright 2010 WENN
